Breaking Down Shanghai Tongji Science&Technology Industrial Co.,Ltd Financial Health: Key Insights for Investors

CN | Industrials | Engineering & Construction | SHH

Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors watching Shanghai Tongji Science & Technology Industrial Co., Ltd. will find a mixed financial portrait: Q1 2025 revenue fell to 903 million yuan (down 9.39% YoY) while TTM revenue as of Nov 3, 2025 stood at 3.58 billion yuan (down 12.02%), and 2024 annual revenue registered 4.17 billion yuan (down 26.44% vs. 2023); yet profitability shows resilience with Q1 2025 net income attributable to shareholders of 87.52 million yuan (up 16.97% YoY), a TTM net profit margin near 7.4% and EPS of 0.43 yuan, even as valuation metrics signal premium expectations - P/E at 37.10 and P/S at 2.58 against a market cap of 9.22 billion yuan; the balance sheet reveals conservative posture with cash and equivalents of 2.47 billion yuan versus total debt of 2.34 billion yuan (total debt-to-equity 36.13%) but liquidity pressures persist (current ratio 1.371, quick ratio 0.73) alongside modest operating cash flow (TTM 153.18 million yuan) and strategic growth levers such as a planned 55% acquisition of Tongji Testing, potential EPS expansion to 0.70 by 2025 per analyst expectations, and a 0.20 yuan dividend (≈31% payout ratio)-read on for a line-by-line breakdown of revenue drivers, margins, leverage, valuation and risks that investors need to weigh.

Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) - Revenue Analysis

Recent topline trends show sustained pressure on Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) revenue across multiple horizons: quarterly, annual, and TTM figures indicate declines that are material for investors assessing growth durability and valuation.

Period Revenue (CNY) Change vs. Prior Period Notes
Q1 2025 903,000,000 -9.39% YoY Quarterly weakness
TTM as of 2025-11-03 3,580,000,000 -12.02% YoY Trailing twelve months
FY 2024 4,170,000,000 -26.44% vs. 2023 Significant annual contraction
Revenue per employee (2024) 1,070,000 - Based on 3,334 employees
Market capitalization (2025-11-03) 9,220,000,000 - Market valuation snapshot
Price-to-Sales (P/S) 2.58 - Market valuation relative to revenue
  • Topline compression: FY2024 revenue down 26.44% vs. 2023, with TTM (-12.02%) and Q1 2025 (-9.39% YoY) confirming persisting decline.
  • Operational efficiency: revenue per employee ~1.07 million CNY suggests headcount scale (3,334 employees) relative to revenue generation.
  • Valuation context: market cap 9.22 billion CNY and P/S 2.58 imply the market prices continued revenue recovery potential rather than current growth momentum.

Key implications for investors include monitoring quarterly revenue trajectory for signs of stabilization or further deterioration, evaluating margins and cash flow to see if the company can sustain operations at lower revenue levels, and comparing P/S to peers for relative valuation. For broader investor context and shareholder composition, see: Exploring Shanghai Tongji Science&Technology Industrial Co.,Ltd Investor Profile: Who's Buying and Why?

Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) - Profitability Metrics

Key profitability indicators for Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) reveal a company with modest margins, improving short-term earnings and steady capital efficiency. Below are the principal metrics investors should note for recent performance and trailing twelve-month (TTM) measures.

  • Net income attributable to shareholders (Q1 2025): 87.52 million yuan, up 16.97% year-on-year.
  • Net profit margin (TTM): ~7.4%.
  • Earnings per share (EPS, TTM): 0.43 yuan.
  • Return on equity (ROE): 6.3%.
  • Operating margin (TTM): 6.16%.
  • Gross margin: 14.03%.
Metric Value Period Interpretation
Net income attributable to shareholders 87.52 million CNY Q1 2025 Double-digit YoY growth (16.97%) indicating improved quarterly profitability
Net profit margin 7.4% TTM Moderate conversion of revenue to net earnings
EPS 0.43 CNY TTM Per-share earnings supporting valuation models
ROE 6.3% Latest reported Modest shareholder return; room for improvement in capital efficiency
Operating margin 6.16% TTM Operational profitability after operating expenses
Gross margin 14.03% Latest reported Indicates the percentage of revenue remaining after COGS

For context on strategic direction and how these profitability metrics tie into long-term plans, see: Mission Statement, Vision, & Core Values (2026) of Shanghai Tongji Science&Technology Industrial Co.,Ltd.

Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) - Debt vs. Equity Structure

Key balance-sheet metrics as of the latest reported dates show a conservative capital structure with substantial liquidity relative to liabilities.

Metric Value Unit / Note
Total debt (as of 2025-03-31) 1.33 billion yuan
Total debt (aggregate referenced) 2.34 billion yuan
Debt-to-equity ratio 36.13% total debt / shareholders' equity
Current ratio 1.371 current assets / current liabilities
Cash and cash equivalents 2.47 billion yuan
Book value per share 5.819 yuan per share
  • Liquidity buffer: cash and equivalents (2.47 billion yuan) roughly match or exceed the referenced total debt figure (2.34 billion yuan), reducing refinancing risk.
  • Moderate leverage: a 36.13% debt-to-equity ratio signals balanced use of debt without aggressive gearing.
  • Short-term coverage: current ratio of 1.371 indicates short-term assets sufficiently cover current liabilities, though not excessively high.
  • Per-share backing: book value per share of 5.819 yuan provides an equity floor for shareholders.

Implications for capital allocation and investor risk:

  • Financial flexibility - near-parity of cash to debt allows the company to service obligations while retaining capacity for opportunistic investment or acquisitions.
  • Resilience to shocks - moderate leverage combined with positive current ratio reduces operational and solvency risk in downturns.
  • Return vs. safety trade-off - conservative balance sheet supports stability but may constrain return-enhancing leverage strategies.

For broader context on corporate direction and values that may affect capital decisions, see: Mission Statement, Vision, & Core Values (2026) of Shanghai Tongji Science&Technology Industrial Co.,Ltd.

Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) - Liquidity and Solvency

Key liquidity and solvency metrics for Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) show a generally conservative balance-sheet posture with specific short-term liquidity constraints if inventory cannot be converted quickly.

  • Current ratio: 1.371 - sufficient to cover short-term liabilities with short-term assets, but not overly liquid.
  • Quick ratio: 0.73 - below 1.0, indicating reliance on inventory to meet near-term obligations.
  • Operating cash flow (TTM): ¥153.18 million - positive cash from core operations.
  • Half-year net income (6/30/2025): ¥146.34 million vs. ¥233.24 million (6/30/2024) - notable year-over-year decline.
  • Cash & cash equivalents: ¥2.47 billion vs. Total debt: ¥2.34 billion - cash roughly covers gross debt.
  • Total debt-to-equity ratio: 36.13% - moderate leverage.
Metric Value Context/Implication
Current Ratio 1.371 Meets short-term obligations but limited buffer
Quick Ratio 0.73 Potential difficulty covering liabilities without selling inventory
Operating Cash Flow (TTM) ¥153.18 million Positive operational cash generation
Net Income (H1 2025) ¥146.34 million Down from ¥233.24 million in H1 2024
Cash & Cash Equivalents ¥2.47 billion Significant liquidity reserve
Total Debt ¥2.34 billion Comparable to cash holdings
Debt-to-Equity Ratio 36.13% Moderate leverage; conservative capital structure

Practical takeaways:

  • Liquidity profile is stabilized by large cash balances, but the quick ratio below 1 signals potential short-term pressure if inventory turnover slows.
  • Operating cash flow is positive but modest relative to cash holdings, and the H1 2025 net income decline warrants monitoring of profitability trends and drivers.
  • Debt levels are moderate; with ¥2.47 billion cash against ¥2.34 billion debt the company holds a net cash-like position on a gross basis, supporting solvency metrics and financial flexibility.

For broader strategic context and corporate priorities, see: Mission Statement, Vision, & Core Values (2026) of Shanghai Tongji Science&Technology Industrial Co.,Ltd.

Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) Valuation Analysis

This section breaks down market valuation and balance-sheet context for Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) using the latest available figures (as of November 3, 2025) to help investors gauge relative price levels, profitability per share, revenue valuation and leverage posture.

  • Price-to-Earnings (P/E): 37.10 - the market is pricing the stock at 37.10 times trailing earnings, implying relatively high expectations for future growth or momentum in earnings quality.
  • Price-to-Sales (P/S): 2.58 - investors pay 2.58 yuan per yuan of revenue, a moderate revenue multiple versus peers in industrial/technology segments.
  • Earnings Per Share (TTM EPS): 0.43 yuan - the base earnings used in the P/E calculation.
  • Market Capitalization: 9.22 billion yuan (as of 2025-11-03) - the company's total listed equity value.
  • Liquidity vs. Debt: Cash and cash equivalents 2.47 billion yuan; Total debt 2.34 billion yuan - a net cash/low-net-debt position supporting financial flexibility.
  • Total Debt-to-Equity: 36.13% - moderate leverage, indicating conservative capital structure relative to equity base.
Metric Value Notes
Price-to-Earnings (P/E) 37.10 Trailing twelve months basis
Price-to-Sales (P/S) 2.58 Market cap / Revenue
Earnings Per Share (EPS, TTM) 0.43 yuan Used for P/E calculation
Market Capitalization 9.22 billion yuan As of 2025-11-03
Cash & Cash Equivalents 2.47 billion yuan Highly liquid buffer
Total Debt 2.34 billion yuan Includes short- and long-term borrowings
Total Debt-to-Equity 36.13% Moderate leverage level

For context on the company's broader background, ownership and business model, see: Shanghai Tongji Science&Technology Industrial Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) - Risk Factors

Key financial metrics and trends that investors should weigh when assessing risk exposure for Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS):

  • Profitability pressure: reported net profit margin of 7.4%, signaling limited operating leverage and thinner buffers against cost shocks or revenue declines.
  • Liquidity constraint: quick ratio of 0.73, indicating potential difficulty meeting short-term liabilities without relying on inventory conversion or external financing.
  • Leverage profile: total debt-to-equity ratio of 36.13%, a moderate leverage level that increases fixed-charge and refinancing risk in tougher markets.
  • Cash vs. debt: cash and cash equivalents of ¥2.47 billion versus total debt of ¥2.34 billion - a conservative liquidity cushion but one that must be managed carefully if earnings weaken.
  • Declining earnings: net income fell to ¥146.34 million for the half-year ended June 30, 2025, from ¥233.24 million in the same period a year earlier, highlighting earnings volatility and potential margin compression.
  • Recurring margin concern: the 7.4% net profit margin repeats as a persistent constraint on capital accumulation and reinvestment capacity.
Metric Value Period / Note
Net Profit Margin 7.4% Reported (persistent)
Quick Ratio 0.73 Short-term liquidity
Cash & Cash Equivalents ¥2.47 billion On balance sheet
Total Debt ¥2.34 billion On balance sheet
Total Debt-to-Equity Ratio 36.13% Capital structure
Net Income - H1 2025 ¥146.34 million Half-year ended 30 Jun 2025
Net Income - H1 2024 ¥233.24 million Half-year ended 30 Jun 2024

Risk implications for investors:

  • With a 7.4% net margin, adverse revenue or cost shifts could quickly erode profits and cash flow available for dividends, capex, or debt service.
  • A quick ratio below 1.0 means working capital management and AR/receivable conversion are critical; unexpected draws on liquidity could force asset sales or short-term borrowings.
  • Although cash slightly exceeds total debt (¥2.47bn vs ¥2.34bn), a declining net income trend (¥146.34m vs ¥233.24m y/y) reduces internal funding capacity and increases sensitivity to interest rate or refinancing cycles.
  • Moderate debt-to-equity (36.13%) provides some financial flexibility, but capital-intensive investments or M&A could raise leverage quickly if not funded by improved operating cash flow.
  • Repeated emphasis on the 7.4% margin underscores limited margin of safety; operational or market disruptions may have outsized effects on valuation and credit metrics.

For broader context on corporate background, governance and business model: Shanghai Tongji Science&Technology Industrial Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) - Growth Opportunities

  • Planned acquisition: proposed purchase of a 55% stake in Tongji Testing to extend the engineering consulting industry chain and capture testing/validation margins.
  • EPS trajectory: analysts project EPS rising from $0.50 in 2023 to $0.70 by 2025, implying ~40% cumulative EPS growth over two years.
  • International partnerships: strategic alliances with overseas firms to co-develop advanced materials and technologies, aiming to upgrade product mix and expand addressable markets.
  • Shareholder returns: dividend per share of 0.20 yuan, representing a payout ratio of approximately 31% on current EPS.
  • Conservative balance sheet: cash and cash equivalents of 2.47 billion yuan against total debt of 2.34 billion yuan, supporting acquisitions and R&D spending.
  • Leverage profile: total debt-to-equity ratio of 36.13%, indicating a moderate debt load that allows room for strategic investment without aggressive refinancing risk.
Metric Value / Projection Notes
Planned acquisition 55% stake in Tongji Testing Strengthens engineering consulting chain
EPS (2023) $0.50 Reported / consensus base
EPS (2025 projected) $0.70 Analysts' projection
Dividend per share 0.20 yuan Payout ratio ≈ 31%
Cash & cash equivalents 2.47 billion yuan Provides liquidity for M&A / capex
Total debt 2.34 billion yuan Manageable given cash position
Total debt-to-equity 36.13% Moderate leverage
  • Revenue growth drivers: expanding consulting/testing services via Tongji Testing acquisition, higher-margin materials/tech from international collaborations, and cross-selling within existing industrial customer base.
  • Capital allocation priorities: targeted M&A (55% Tongji Testing), continued R&D partnerships, and maintaining shareholder distributions (0.20 yuan DPS).
  • Risk considerations: integration risk from the Tongji Testing acquisition, execution risk on international tech partnerships, and currency/market exposure tied to overseas collaborations.
Exploring Shanghai Tongji Science&Technology Industrial Co.,Ltd Investor Profile: Who's Buying and Why?

DCF model

Shanghai Tongji Science&Technology Industrial Co.,Ltd (600846.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.